JP2020524143A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020524143A5 JP2020524143A5 JP2019569758A JP2019569758A JP2020524143A5 JP 2020524143 A5 JP2020524143 A5 JP 2020524143A5 JP 2019569758 A JP2019569758 A JP 2019569758A JP 2019569758 A JP2019569758 A JP 2019569758A JP 2020524143 A5 JP2020524143 A5 JP 2020524143A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- bioactive agent
- lipid
- oil
- sorbitan ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024000126A JP2024029173A (ja) | 2017-06-15 | 2024-01-04 | ナノ構造脂質担体、安定エマルジョン、およびその使用 |
Applications Claiming Priority (21)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762520204P | 2017-06-15 | 2017-06-15 | |
| US62/520,204 | 2017-06-15 | ||
| US201762540973P | 2017-08-03 | 2017-08-03 | |
| US62/540,973 | 2017-08-03 | ||
| US201762556291P | 2017-09-08 | 2017-09-08 | |
| US62/556,291 | 2017-09-08 | ||
| US201762563544P | 2017-09-26 | 2017-09-26 | |
| US62/563,544 | 2017-09-26 | ||
| US201762582859P | 2017-11-07 | 2017-11-07 | |
| US62/582,859 | 2017-11-07 | ||
| US201862622748P | 2018-01-26 | 2018-01-26 | |
| US201862622755P | 2018-01-26 | 2018-01-26 | |
| US62/622,748 | 2018-01-26 | ||
| US62/622,755 | 2018-01-26 | ||
| US201862669262P | 2018-05-09 | 2018-05-09 | |
| US62/669,262 | 2018-05-09 | ||
| US201862677336P | 2018-05-29 | 2018-05-29 | |
| US62/677,336 | 2018-05-29 | ||
| US201862680454P | 2018-06-04 | 2018-06-04 | |
| US62/680,454 | 2018-06-04 | ||
| PCT/US2018/037783 WO2018232257A1 (en) | 2017-06-15 | 2018-06-15 | Nanostructured lipid carriers and stable emulsions and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024000126A Division JP2024029173A (ja) | 2017-06-15 | 2024-01-04 | ナノ構造脂質担体、安定エマルジョン、およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020524143A JP2020524143A (ja) | 2020-08-13 |
| JP2020524143A5 true JP2020524143A5 (cg-RX-API-DMAC7.html) | 2021-07-29 |
| JP7866358B2 JP7866358B2 (ja) | 2026-05-27 |
Family
ID=62948328
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019569758A Active JP7866358B2 (ja) | 2017-06-15 | 2018-06-15 | ナノ構造脂質担体、安定エマルジョン、およびその使用 |
| JP2024000126A Withdrawn JP2024029173A (ja) | 2017-06-15 | 2024-01-04 | ナノ構造脂質担体、安定エマルジョン、およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024000126A Withdrawn JP2024029173A (ja) | 2017-06-15 | 2024-01-04 | ナノ構造脂質担体、安定エマルジョン、およびその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US11141377B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3638207B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7866358B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR102673794B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN111315362A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018285694B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112019026615B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3067224A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3003260T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL271384B2 (cg-RX-API-DMAC7.html) |
| MX (4) | MX2019015076A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018232257A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201908207B (cg-RX-API-DMAC7.html) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018285694B2 (en) | 2017-06-15 | 2025-04-10 | Access To Advanced Health Institute | Nanostructured lipid carriers and stable emulsions and uses thereof |
| US12180370B2 (en) | 2019-01-15 | 2024-12-31 | Nant Holdings Ip, Llc | Aragonite uses |
| US12514796B2 (en) | 2019-01-15 | 2026-01-06 | Nant Holdings Ip, Llc | Aragonite compositions, methods, and uses thereof |
| US20220339116A1 (en) * | 2019-04-03 | 2022-10-27 | The Johns Hopkins University | Lipid nanoparticles as oral vehicles of immunotherapy |
| US11679163B2 (en) | 2019-09-20 | 2023-06-20 | Hdt Bio Corp. | Compositions and methods for delivery of RNA |
| WO2021194672A1 (en) | 2020-03-23 | 2021-09-30 | Hdt Bio Corp. | Compositions and methods for delivery of rna |
| EP4058581A1 (en) * | 2019-11-15 | 2022-09-21 | Infectious Disease Research Institute | Rig-i agonist and adjuvant formulation for tumor treatment |
| AU2021226149A1 (en) * | 2020-02-26 | 2022-10-06 | Capcium Inc. | Nanostructure lipid carrier delivery system, composition, and methods |
| CN111494619B (zh) * | 2020-04-26 | 2022-03-18 | 南京农业大学 | 一种基于角鲨烯的阳离子纳米结构脂质载体免疫佐剂的制备方法 |
| US20230310323A1 (en) | 2020-09-04 | 2023-10-05 | Access To Advanced Health Institute | Co-lyophilized rna and nanostructured lipid carrier |
| WO2022051024A1 (en) | 2020-09-04 | 2022-03-10 | Infectious Disease Research Institute | Genetically-adjuvanted rna vaccines |
| JP2024501949A (ja) * | 2020-12-23 | 2024-01-17 | アクセス ツー アドバンスト ヘルス インスティチュート | ソラネソールワクチンアジュバント及びその調製方法 |
| US20240252620A1 (en) * | 2021-05-28 | 2024-08-01 | The Regents Of The University Of Michigan | Combined agonist adjuvant for coronavirus vaccine |
| IN202121031414A (cg-RX-API-DMAC7.html) * | 2021-07-13 | 2023-01-13 | ||
| US20240327492A1 (en) | 2021-07-29 | 2024-10-03 | Nantcell, Inc. | Modified T Cell Receptors For The Prevention And Treatment Of Viral Infections And Cancer |
| KR102681030B1 (ko) * | 2021-08-02 | 2024-07-02 | 한국화학연구원 | 올리고뉴클레오타이드가 봉입된 나노입자, 이의 제조방법 및 이를 포함하는 약학적 제제 |
| US20250134991A1 (en) * | 2021-08-20 | 2025-05-01 | Thomas Jefferson University | Monophosphoryl lipid adjuvant (mpla) compositions, vaccine compositions thereof, and methods of preparing and using the same |
| AU2022352486A1 (en) * | 2021-09-22 | 2024-04-11 | Hdt Bio Corp. | Dried nanoparticle compositions |
| JP2024535352A (ja) | 2021-09-22 | 2024-09-30 | エイチディーティー バイオ コーポレーション | Sars-cov-2 rnaワクチン組成物および使用方法 |
| CA3232658A1 (en) | 2021-09-22 | 2023-03-30 | Steven Gregory REED | Rna vaccines against infectious diseases |
| CA3232562A1 (en) * | 2021-09-22 | 2023-03-30 | Malcolm S. Duthie | Nucleic acid sensor agonist compositions and uses thereof |
| AU2022358446A1 (en) * | 2021-09-22 | 2024-04-18 | Hdt Bio Corp. | Compositions and methods for enhanced protein production |
| WO2023049636A2 (en) * | 2021-09-22 | 2023-03-30 | Hdt Bio Corp. | Cancer therapy compositions and uses thereof |
| EP4460326A4 (en) * | 2022-01-07 | 2026-03-11 | Hdt Bio Corp | COMPOSITIONS AND METHODS ASSOCIATED WITH MULTIVALENT IMMUNE RESPONSES |
| WO2023228116A1 (en) | 2022-05-24 | 2023-11-30 | Access To Advanced Health Institute | Intranasal administration of thermostable rna vaccines |
| EP4547258A4 (en) * | 2022-06-28 | 2026-08-05 | Transcode Therapeutics Inc | Matrix-Directed Rig-I Agonitor Nanoparticles and Precursor Compositions and Their Uses in Cancer Therapy |
| KR102901149B1 (ko) * | 2022-09-05 | 2025-12-17 | 주식회사 차백신연구소 | 에멀전 제형의 면역증강제 조성물 및 이의 제조 방법 |
| WO2024052882A1 (en) | 2022-09-09 | 2024-03-14 | Access To Advanced Health Institute | Immunogenic vaccine composition incorporating a saponin |
| CN116159145B (zh) * | 2023-01-31 | 2025-04-22 | 四川大学 | 含七叶皂苷和/或其盐化合物的转染复合物在促转染的应用 |
| CN116392586B (zh) * | 2023-04-12 | 2025-06-24 | 江苏中慧元通生物科技股份有限公司 | 一种纳米乳佐剂 |
| EP4694920A1 (en) * | 2023-04-14 | 2026-02-18 | BioNTech SE | Rna for preventing or treating tuberculosis |
| EP4734962A1 (en) * | 2023-06-29 | 2026-05-06 | RIGImmune Inc. | Novel formulations |
| WO2025244961A1 (en) * | 2024-05-22 | 2025-11-27 | Merck Sharp & Dohme Llc | Processes for making stable nanoemulsion adjuvants |
| WO2026096272A1 (en) * | 2024-10-30 | 2026-05-07 | Virginia Commonwealth University | Equine lyme disease vaccines and methods |
| ES3069647A1 (es) * | 2024-12-09 | 2026-06-09 | Consejo Superior Investigacion | Transportadores lipídicos nanoestructurados para inhibir la formación de biopelículas bacterianas |
| CN121944103B (zh) * | 2026-04-03 | 2026-07-03 | 华诺泰生物医药科技(成都)有限公司 | 一种含角鲨烯的水包油佐剂及其制备方法与应用 |
Family Cites Families (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4866034A (en) | 1982-05-26 | 1989-09-12 | Ribi Immunochem Research Inc. | Refined detoxified endotoxin |
| US4436727A (en) | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| FI861417A0 (fi) | 1985-04-15 | 1986-04-01 | Endotronics Inc | Hepatitis b ytantigen framstaelld med rekombinant-dna-teknik, vaccin, diagnostiskt medel och cellinjer samt foerfaranden foer framstaellning daerav. |
| US4877611A (en) | 1986-04-15 | 1989-10-31 | Ribi Immunochem Research Inc. | Vaccine containing tumor antigens and adjuvants |
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| EP0304578B1 (en) | 1987-06-22 | 2001-10-24 | Medeva Holdings Bv | Peptide comprising hepatitis B surface antigen |
| US4897268A (en) | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| GB8819209D0 (en) | 1988-08-12 | 1988-09-14 | Research Corp Ltd | Polypeptide & dna encoding same |
| US4999403A (en) | 1988-10-28 | 1991-03-12 | Exxon Chemical Patents Inc. | Graft polymers of functionalized ethylene-alpha-olefin copolymer with polypropylene, methods of preparation, and use in polypropylene compositions |
| JP3237842B2 (ja) | 1988-12-16 | 2001-12-10 | オランダ国 | ニューモリシンミュータント及びそれから製造されたニューモコッカルワクチン |
| ATE115862T1 (de) | 1989-02-04 | 1995-01-15 | Akzo Nobel Nv | Tocole als impfstoffadjuvans. |
| DK0414374T3 (da) | 1989-07-25 | 1998-03-09 | Smithkline Beecham Biolog | Hidtil ukendte antigener og fremgangsmåder til fremstilling deraf |
| US5256643A (en) | 1990-05-29 | 1993-10-26 | The Government Of The United States | Human cripto protein |
| EP1359156B1 (en) | 1991-07-19 | 2007-03-07 | University of Queensland | Vaccine against Human Papillomavirus (Type 18) |
| JP3954643B2 (ja) | 1991-11-16 | 2007-08-08 | グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム | マラリア原虫由来のCSおよびHBsAG間のハイブリッド蛋白質 |
| PT647140E (pt) | 1992-06-25 | 2007-12-27 | Univ Georgetown | Vacinas de papilomavírus |
| US5786148A (en) | 1996-11-05 | 1998-07-28 | Incyte Pharmaceuticals, Inc. | Polynucleotides encoding a novel prostate-specific kallikrein |
| US5437951A (en) | 1992-09-03 | 1995-08-01 | The United States Of America As Represented By The Department Of Health And Human Services | Self-assembling recombinant papillomavirus capsid proteins |
| DE69434383T2 (de) | 1993-03-09 | 2005-11-24 | The University Of Rochester | Herstellung von menschlichem papillomavirus hüllprotein und virus-ähnlichen teilchen |
| US6015686A (en) | 1993-09-15 | 2000-01-18 | Chiron Viagene, Inc. | Eukaryotic layered vector initiation systems |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| US5688506A (en) | 1994-01-27 | 1997-11-18 | Aphton Corp. | Immunogens against gonadotropin releasing hormone |
| AU713040B2 (en) | 1994-07-15 | 1999-11-18 | University Of Iowa Research Foundation, The | Immunomodulatory oligonucleotides |
| EP1728800A1 (de) | 1994-10-07 | 2006-12-06 | Loyola University Of Chicago | Papillomavirusähnliche Partikel, Fusionsproteine sowie Verfahren zu deren Herstellung |
| AU4727296A (en) | 1995-02-24 | 1996-09-11 | Cantab Pharmaceuticals Research Limited | Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation |
| US5843464A (en) | 1995-06-02 | 1998-12-01 | The Ohio State University | Synthetic chimeric fimbrin peptides |
| US5981215A (en) | 1995-06-06 | 1999-11-09 | Human Genome Sciences, Inc. | Human criptin growth factor |
| US6451592B1 (en) | 1996-04-05 | 2002-09-17 | Chiron Corporation | Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| ES2301178T3 (es) | 1996-04-05 | 2008-06-16 | Novartis Vaccines & Diagnostic | Vectores basados en alfavirus recombinantes con inhibicion reducida de la sintesis macromolecular celular. |
| US5856462A (en) | 1996-09-10 | 1999-01-05 | Hybridon Incorporated | Oligonucleotides having modified CpG dinucleosides |
| US5955306A (en) | 1996-09-17 | 1999-09-21 | Millenium Pharmaceuticals, Inc. | Genes encoding proteins that interact with the tub protein |
| US5840871A (en) | 1997-01-29 | 1998-11-24 | Incyte Pharmaceuticals, Inc. | Prostate-associated kallikrein |
| CA2281954A1 (en) | 1997-02-25 | 1998-08-27 | Corixa Corporation | Compounds for immunodiagnosis of prostate cancer and methods for their use |
| GB9711990D0 (en) | 1997-06-11 | 1997-08-06 | Smithkline Beecham Biolog | Vaccine |
| AU740956B2 (en) | 1997-07-21 | 2001-11-15 | Baxter Healthcare Sa | Modified immunogenic pneumolysin compositions as vaccines |
| GB9717953D0 (en) | 1997-08-22 | 1997-10-29 | Smithkline Beecham Biolog | Vaccine |
| EP1279401B1 (en) | 1997-09-05 | 2008-01-09 | GlaxoSmithKline Biologicals S.A. | Oil in water emulsions containing saponins |
| GB9718901D0 (en) | 1997-09-05 | 1997-11-12 | Smithkline Beecham Biolog | Vaccine |
| US7459524B1 (en) | 1997-10-02 | 2008-12-02 | Emergent Product Development Gaithersburg Inc. | Chlamydia protein, sequence and uses thereof |
| KR100760221B1 (ko) | 1997-11-28 | 2007-10-30 | 세로노 제네틱스 인스티튜트 에스.에이. | 클라미디아 트라코마티스 게놈 서열과 폴리펩티드, 이의단편 및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도 |
| GB9727262D0 (en) | 1997-12-24 | 1998-02-25 | Smithkline Beecham Biolog | Vaccine |
| BR9907691B1 (pt) | 1998-02-05 | 2011-05-31 | derivado de antìgeno e antìgeno da famìlia mage associado a tumor, seqüência de ácido nucléico, codificando os mesmos, seus usos na preparação de vacina, processo para produção de vacina e vacina. | |
| BR9909472A (pt) | 1998-04-07 | 2001-09-11 | Corixa Corp | Polipeptìdeo purificado, processo para prevenir tuberculose, e, composição farmacêutica |
| JP2002511266A (ja) | 1998-04-15 | 2002-04-16 | ルードヴィッヒ インスティテュート フォー キャンサー リサーチ | 腫瘍関連核酸及びその使用 |
| TR200100916T2 (cg-RX-API-DMAC7.html) | 1998-07-14 | 2002-06-21 | Corixa@@Corporation | |
| DK1187629T3 (da) | 1999-04-19 | 2005-01-17 | Glaxosmithkline Biolog Sa | Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid |
| US6533949B1 (en) | 2000-08-28 | 2003-03-18 | Nanopass Ltd. | Microneedle structure and production method therefor |
| US20030138453A1 (en) | 2000-09-28 | 2003-07-24 | O'hagan Derek | Microparticles for delivery of heterologous nucleic acids |
| WO2004058166A2 (en) | 2002-12-23 | 2004-07-15 | Vical Incorporated | Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| US7998119B2 (en) | 2003-11-18 | 2011-08-16 | Nano Pass Technologies Ltd. | System and method for delivering fluid into flexible biological barrier |
| JP5331340B2 (ja) | 2004-05-18 | 2013-10-30 | バイカル インコーポレイテッド | インフルエンザウィルスワクチン組成物、及びその使用方法 |
| EP2468300B1 (en) | 2006-09-26 | 2017-12-20 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
| WO2008124647A2 (en) | 2007-04-04 | 2008-10-16 | Infectious Disease Research Institute | Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof |
| EP2200639B1 (en) * | 2007-09-24 | 2016-03-30 | Government of the USA, as Represented by the Secretary, Department of Health and Human Services | Immunostimulatory combinations of tlr3 ligands with tlr2 and tlr9 agonists and methods of use |
| CA2764374C (en) | 2009-06-05 | 2019-11-19 | Infectious Disease Research Institute | Synthetic glucopyranosyl lipid adjuvants |
| WO2011076807A2 (en) | 2009-12-23 | 2011-06-30 | Novartis Ag | Lipids, lipid compositions, and methods of using them |
| CA2804591C (en) | 2010-07-06 | 2019-01-22 | Novartis Ag | Cationic oil-in-water emulsions |
| US9770463B2 (en) | 2010-07-06 | 2017-09-26 | Glaxosmithkline Biologicals Sa | Delivery of RNA to different cell types |
| PT3243526T (pt) | 2010-07-06 | 2020-03-04 | Glaxosmithkline Biologicals Sa | Distribuição de arn para despoletar múltiplas vias imunitárias |
| US10487332B2 (en) | 2010-07-06 | 2019-11-26 | Glaxosmithkline Biologicals Sa | Immunisation of large mammals with low doses of RNA |
| US9636410B2 (en) | 2011-07-06 | 2017-05-02 | Glaxosmithkline Biologicals Sa | Cationic oil-in-water emulsions |
| RU2014104090A (ru) * | 2011-07-06 | 2015-08-20 | Новартис Аг | Липосомы с эффективным соотношением n:p для доставки молекул phk |
| US9655845B2 (en) | 2011-07-06 | 2017-05-23 | Glaxosmithkline Biologicals, S.A. | Oil-in-water emulsions that contain nucleic acids |
| US10322089B2 (en) * | 2012-03-14 | 2019-06-18 | The Board Of Trustees Of The Leland Stanford Junior University | Nanoparticles, nanoparticle delivery methods, and systems of delivery |
| US8809388B2 (en) * | 2012-11-06 | 2014-08-19 | Brandeis University | Vegetable oil composition containing palm mid-fraction fat and method of reducing plasma cholesterol |
| AU2014204826A1 (en) * | 2013-01-10 | 2015-07-09 | Seqirus UK Limited | Influenza virus immunogenic compositions and uses thereof |
| CN115837014A (zh) * | 2016-05-18 | 2023-03-24 | 摩登纳特斯有限公司 | 编码松弛素的多核苷酸 |
| AU2018285694B2 (en) | 2017-06-15 | 2025-04-10 | Access To Advanced Health Institute | Nanostructured lipid carriers and stable emulsions and uses thereof |
-
2018
- 2018-06-15 AU AU2018285694A patent/AU2018285694B2/en active Active
- 2018-06-15 MX MX2019015076A patent/MX2019015076A/es unknown
- 2018-06-15 CN CN201880050697.XA patent/CN111315362A/zh active Pending
- 2018-06-15 KR KR1020207001253A patent/KR102673794B1/ko active Active
- 2018-06-15 IL IL271384A patent/IL271384B2/en unknown
- 2018-06-15 CA CA3067224A patent/CA3067224A1/en active Pending
- 2018-06-15 KR KR1020247018651A patent/KR20240096685A/ko not_active Ceased
- 2018-06-15 WO PCT/US2018/037783 patent/WO2018232257A1/en not_active Ceased
- 2018-06-15 US US16/622,908 patent/US11141377B2/en active Active
- 2018-06-15 BR BR112019026615-1A patent/BR112019026615B1/pt active IP Right Grant
- 2018-06-15 EP EP18742621.8A patent/EP3638207B1/en active Active
- 2018-06-15 ES ES18742621T patent/ES3003260T3/es active Active
- 2018-06-15 JP JP2019569758A patent/JP7866358B2/ja active Active
-
2019
- 2019-12-10 ZA ZA2019/08207A patent/ZA201908207B/en unknown
- 2019-12-13 MX MX2023006661A patent/MX2023006661A/es unknown
- 2019-12-13 MX MX2022013322A patent/MX2022013322A/es unknown
- 2019-12-13 MX MX2022013320A patent/MX2022013320A/es unknown
-
2021
- 2021-09-09 US US17/470,874 patent/US12201722B2/en active Active
-
2024
- 2024-01-04 JP JP2024000126A patent/JP2024029173A/ja not_active Withdrawn
- 2024-12-11 US US18/977,878 patent/US20250241854A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chatzikleanthous et al. | Lipid-based nanoparticles for delivery of vaccine adjuvants and antigens: toward multicomponent vaccines | |
| JP7333563B2 (ja) | 脂質ナノ粒子 | |
| JP6505912B2 (ja) | 改良されたアミノ脂質および核酸の送達方法 | |
| Kim et al. | Nanotechnology and vaccine development | |
| Davidsen et al. | Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6, 6′-dibehenate)—a novel adjuvant inducing both strong CMI and antibody responses | |
| JP2013531680A5 (cg-RX-API-DMAC7.html) | ||
| DK2729127T3 (en) | METHODS FOR LIPOSOMES PREPARATION | |
| RU2014104092A (ru) | Эмульсии типа "масло в воде", которые содержат нуклеиновые кислоты | |
| US20170049702A1 (en) | Method to Enhance an Immune Response of Nucleic Acid Vaccination | |
| JP2023518976A (ja) | Rnaを送達するための組成物および方法 | |
| US20110177156A1 (en) | Sterol-Modified Amphiphilic Lipids | |
| JP7821776B2 (ja) | 効率的な核酸送達のための担体 | |
| Paecharoenchai et al. | Structure relationship of cationic lipids on gene transfection mediated by cationic liposomes | |
| EP3147277B1 (en) | Lipid membrane structure for sirna intracellular delivery | |
| CN1980638B (zh) | 用糖脂稳定基于脂质的佐剂制剂的组合物和方法 | |
| Wang et al. | Advances in the study of LNPs for mRNA delivery and clinical applications | |
| JP2024535351A5 (cg-RX-API-DMAC7.html) | ||
| Perrie et al. | Surfactant vesicle-mediated delivery of DNA vaccines via the subcutaneous route | |
| Ahmad et al. | Liposomes and niosomes for targeted drug and gene delivery systems | |
| Nie et al. | Synthetic nanomaterials for spleen-specific mRNA delivery | |
| Porte et al. | A molecular view of lipid nanoparticles: insights into their morphology and structural plasticity | |
| WO2024209013A1 (en) | Lipid nanoparticle compositions | |
| Vaquero et al. | Incorporation of monophosphoryl lipid A and CpG-oligodeoxynucleotides into lipid nanoparticles activates toll-like receptor signaling pathways while maintaining antigen expression for mRNA-based vaccinations | |
| Wölk et al. | Investigation of binary lipid mixtures of a three-chain cationic lipid with phospholipids suitable for gene delivery | |
| JP5390059B2 (ja) | 無菌ポリヌクレオチド系薬剤の製造方法 |